Trial Profile
Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Gemcitabine
- Indications Adenocarcinoma; Biliary cancer
- Focus Therapeutic Use
- Acronyms ECHO
- 09 Feb 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2008 New trial record.